Xaira Therapeutics
189 employees
Biotech/Pharma
Seed · $1.0B
Total raised
$1.0B
Last stage
Seed
Investors
David Baker
Nobel Laureate, Professor of Biochemistry, HHMI Investigator, and Director of the Institute for Protein Design at the University of Washington School of Medicine. Pioneer of RFdiffusion and RFantibody AI protein design models.
Hetu Kamisetty
Former Meta AI scientist leading generative AI initiatives. Holds a PhD in Machine Learning from Carnegie Mellon University. Previously a postdoctoral researcher in David Baker's lab at UW Institute for Protein Design.
Marc Tessier-Lavigne
Former Chief Scientific Officer and EVP of Research at Genentech, and former President of Stanford University and The Rockefeller University. A Rhodes Scholar and elected member of the US National Academy of Sciences.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.